Clinical Trial Update: Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the fluticasone furoate/vilanterol fixed-dose combination versus fluticasone furoate alone in adults with as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone furoate (Flovent) (Fluticasone furoate)
• Fluticasone furoate/vilanterol (Breo Ellipta) (Fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2022-10-12